153 related articles for article (PubMed ID: 30052144)
1. Exploring binding modes of the selected inhibitors to phosphodiesterase delta by all-atom molecular dynamics simulations and free energy calculations.
Zhong H; Zhang YJ; Shan XB
J Biomol Struct Dyn; 2019 Jun; 37(9):2415-2429. PubMed ID: 30052144
[TBL] [Abstract][Full Text] [Related]
2. Identification of pyrazolopyridazinones as PDEδ inhibitors.
Papke B; Murarka S; Vogel HA; Martín-Gago P; Kovacevic M; Truxius DC; Fansa EK; Ismail S; Zimmermann G; Heinelt K; Schultz-Fademrecht C; Al Saabi A; Baumann M; Nussbaumer P; Wittinghofer A; Waldmann H; Bastiaens PI
Nat Commun; 2016 Apr; 7():11360. PubMed ID: 27094677
[TBL] [Abstract][Full Text] [Related]
3. Molecular Simulations of Solved Co-crystallized X-Ray Structures Identify Action Mechanisms of PDEδ Inhibitors.
Salmas RE; Mestanoglu M; Yurtsever M; Noskov SY; Durdagi S
Biophys J; 2015 Sep; 109(6):1163-8. PubMed ID: 26340817
[TBL] [Abstract][Full Text] [Related]
4. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of the association and dissociation of Deltarasin from the heterodimeric KRas4B-PDEδ complex.
Bello M; Correa-Basurto J; Vargas-Mejía MÁ
Biopolymers; 2019 Nov; 110(11):e23333. PubMed ID: 31568570
[TBL] [Abstract][Full Text] [Related]
7. DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras.
Majrashi TA; Sabt A; Almahli H; El Hassab MA; Noamaan MA; Elkaeed EB; Hamissa MF; Maslamani AN; Shaldam MA; Eldehna WM
PLoS One; 2024; 19(3):e0300035. PubMed ID: 38457483
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling, docking studies and molecular dynamic simulations using graphical processing unit architecture to probe the type-11 phosphodiesterase catalytic site: a computational approach for the rational design of selective inhibitors.
Cichero E; D'Ursi P; Moscatelli M; Bruno O; Orro A; Rotolo C; Milanesi L; Fossa P
Chem Biol Drug Des; 2013 Dec; 82(6):718-31. PubMed ID: 23865680
[TBL] [Abstract][Full Text] [Related]
9. Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis.
Wu Q; Gao Q; Guo H; Li D; Wang J; Gao W; Han C; Li Y; Yang L
Mol Biosyst; 2013 Mar; 9(3):386-97. PubMed ID: 23354020
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
Zimmermann G; Papke B; Ismail S; Vartak N; Chandra A; Hoffmann M; Hahn SA; Triola G; Wittinghofer A; Bastiaens PI; Waldmann H
Nature; 2013 May; 497(7451):638-42. PubMed ID: 23698361
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
12. The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.
Feng TT; Zhang YJ; Chen H; Fan S; Han JG
J Biomol Struct Dyn; 2016; 34(3):517-28. PubMed ID: 25933061
[TBL] [Abstract][Full Text] [Related]
13. Exploration of Novel PDEδ Inhibitor Based on Pharmacophore and Molecular Docking against KRAS Mutant in Colorectal Cancer.
Mouhcine M; Kadil Y; Rahmoune I; Filali H
Curr Drug Discov Technol; 2023; 20(4):e160423215830. PubMed ID: 37066770
[TBL] [Abstract][Full Text] [Related]
14. Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.
Höfgen N; Stange H; Schindler R; Lankau HJ; Grunwald C; Langen B; Egerland U; Tremmel P; Pangalos MN; Marquis KL; Hage T; Harrison BL; Malamas MS; Brandon NJ; Kronbach T
J Med Chem; 2010 Jun; 53(11):4399-411. PubMed ID: 20450197
[TBL] [Abstract][Full Text] [Related]
15. An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders.
Sharma B; Bhattacherjee D; Zyryanov GV; Purohit R
J Biomol Struct Dyn; 2023 Nov; 41(19):9424-9436. PubMed ID: 36336960
[TBL] [Abstract][Full Text] [Related]
16. Exploring binding modes of the selected inhibitors to SND1 by all-atom molecular dynamics simulations.
Pang P; Liu S; Hao X; Tian Y; Gong S; Miao D; Zhang Y
J Biomol Struct Dyn; 2024 Jul; 42(11):5536-5550. PubMed ID: 37345536
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations.
Song LT; Tu J; Liu RR; Zhu M; Meng YJ; Zhai HL
J Biomol Struct Dyn; 2019 Jul; 37(11):2970-2979. PubMed ID: 30058436
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the binding of benzimidazole-biphenyl derivatives to hemoglobin using docking and molecular dynamics simulation.
Li J; Shi R; Yang C; Zhu X
Int J Biol Macromol; 2011 Jan; 48(1):20-6. PubMed ID: 20869392
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors.
Zhong H; Huang W; He G; Peng C; Wu F; Ouyang L
Int J Mol Sci; 2013 May; 14(5):9947-62. PubMed ID: 23665899
[TBL] [Abstract][Full Text] [Related]
20. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
